ResMed Announces Participation in the Citi Healthcare Conference
ResMed (NYSE: RMD) announces that CEO Mick Farrell will participate in a virtual fireside chat at the Citi Healthcare Conference on February 23, 2022, at 12:30 p.m. EST. This event will be accessible via webcast, with a replay available for 24 hours post-event until February 23, 2023. ResMed specializes in innovative solutions for chronic diseases, particularly focusing on digital health technologies and cloud-connected medical devices aimed at enhancing patient care and reducing healthcare costs globally.
- CEO Mick Farrell's participation in the Citi Healthcare Conference could enhance investor engagement.
- ResMed's focus on digital health technologies positions the company well for future growth in chronic disease management.
- None.
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, beginning at approximately 12:30 p.m. (Eastern Standard Time) via webcast.
More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through February 23, 2023.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media | ||
| Amy Wakeham | Jayme Rubenstein | ||
| +1 858.836.5000 | +1 858.836.6798 | ||
| investorrelations@resmed.com | news@resmed.com |
FAQ
When is ResMed's CEO participating in the Citi Healthcare Conference?
How can I access the webcast of the Citi Healthcare Conference featuring ResMed?
What is the primary focus of ResMed's business?
What is the stock symbol for ResMed?
